| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |